Healthcare provider profile · identity verified

Blake Mcconnell, MD

Family Practice · SALEM, OR · NPI 1063074789

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	270	86
Levothyroxine Sodium	Levothyroxine Sodium	200	59
Lisinopril	Lisinopril	180	55
Amlodipine Besylate	Amlodipine Besylate	163	51
Gabapentin	Gabapentin	145	40
Losartan Potassium	Losartan Potassium	112	38
Omeprazole	Omeprazole	111	38
Rosuvastatin Calcium	Rosuvastatin Calcium	109	34
Metformin Hcl Er	Metformin Hcl	99	27
Metoprolol Succinate	Metoprolol Succinate	84	28
Tamsulosin Hcl	Tamsulosin Hcl	80	28
Metformin Hcl	Metformin Hcl	78	27
Trazodone Hcl	Trazodone Hcl	73	25
Albuterol Sulfate Hfa	Albuterol Sulfate	68	27
Hydrochlorothiazide	Hydrochlorothiazide	62	21
Eliquis	Apixaban	61	13
Alendronate Sodium	Alendronate Sodium	58	15
Jardiance	Empagliflozin	56	15
Duloxetine Hcl	Duloxetine Hcl	54	24
Ozempic	Semaglutide	49	suppressed
Simvastatin	Simvastatin	48	16
Furosemide	Furosemide	47	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	11
Trulicity	Dulaglutide	44	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	41	15
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Montelukast Sodium	Montelukast Sodium	37	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Glipizide Er	Glipizide	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	30	13
Donepezil Hcl	Donepezil Hcl	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Ibuprofen	Ibuprofen	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	11
Baclofen	Baclofen	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Valsartan	Valsartan	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	21	suppressed
Sertraline Hcl	Sertraline Hcl	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Glipizide	Glipizide	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Atenolol	Atenolol	15	suppressed
Famotidine	Famotidine	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Carvedilol	Carvedilol	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Prednisone	Prednisone	14	11
Xarelto	Rivaroxaban	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Azelastine Hcl	Azelastine Hcl	13	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Finasteride	Finasteride	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error